220 related articles for article (PubMed ID: 30603331)
1. Immune regulation of glucose and lipid metabolism.
Ota T
Diabetol Int; 2017 Aug; 8(3):257-267. PubMed ID: 30603331
[TBL] [Abstract][Full Text] [Related]
2. Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease.
Xu L; Kitade H; Ni Y; Ota T
Biomolecules; 2015 Jul; 5(3):1563-79. PubMed ID: 26197341
[TBL] [Abstract][Full Text] [Related]
3. Chemokine systems link obesity to insulin resistance.
Ota T
Diabetes Metab J; 2013 Jun; 37(3):165-72. PubMed ID: 23807918
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease.
Farrell GC; Haczeyni F; Chitturi S
Adv Exp Med Biol; 2018; 1061():19-44. PubMed ID: 29956204
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of hepatocyte nuclear factor 1b induces hepatic steatosis through DPP4/NOX1-mediated regulation of superoxide.
Long Z; Cao M; Su S; Wu G; Meng F; Wu H; Liu J; Yu W; Atabai K; Wang X
Free Radic Biol Med; 2017 Dec; 113():71-83. PubMed ID: 28942246
[TBL] [Abstract][Full Text] [Related]
6. From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation.
Lionetti L; Mollica MP; Lombardi A; Cavaliere G; Gifuni G; Barletta A
Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):146-52. PubMed ID: 19171470
[TBL] [Abstract][Full Text] [Related]
7. Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes.
Zatterale F; Longo M; Naderi J; Raciti GA; Desiderio A; Miele C; Beguinot F
Front Physiol; 2019; 10():1607. PubMed ID: 32063863
[TBL] [Abstract][Full Text] [Related]
8. FBXW7 suppresses HMGB1-mediated innate immune signaling to attenuate hepatic inflammation and insulin resistance in a mouse model of nonalcoholic fatty liver disease.
Zhang C; Chen F; Feng L; Shan Q; Zheng GH; Wang YJ; Lu J; Fan SH; Sun CH; Wu DM; Li MQ; Hu B; Wang QQ; Zhang ZF; Zheng YL
Mol Med; 2019 Jun; 25(1):29. PubMed ID: 31215394
[TBL] [Abstract][Full Text] [Related]
9. A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease.
Ullah A; Ud Din A; Ding W; Shi Z; Pervaz S; Shen B
Rev Endocr Metab Disord; 2023 Aug; 24(4):611-631. PubMed ID: 37000372
[TBL] [Abstract][Full Text] [Related]
10. DPP-4 Inhibition by Linagliptin Attenuates Obesity-Related Inflammation and Insulin Resistance by Regulating M1/M2 Macrophage Polarization.
Zhuge F; Ni Y; Nagashimada M; Nagata N; Xu L; Mukaida N; Kaneko S; Ota T
Diabetes; 2016 Oct; 65(10):2966-79. PubMed ID: 27445264
[TBL] [Abstract][Full Text] [Related]
11. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
Cusi K
Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
[TBL] [Abstract][Full Text] [Related]
12. Emerging roles of SGLT2 inhibitors in obesity and insulin resistance: Focus on fat browning and macrophage polarization.
Xu L; Ota T
Adipocyte; 2018; 7(2):121-128. PubMed ID: 29376471
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison?
Gruben N; Shiri-Sverdlov R; Koonen DP; Hofker MH
Biochim Biophys Acta; 2014 Nov; 1842(11):2329-2343. PubMed ID: 25128743
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
15. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance.
Asrih M; Jornayvaz FR
J Endocrinol; 2013 Sep; 218(3):R25-36. PubMed ID: 23833274
[TBL] [Abstract][Full Text] [Related]
16. Decoding cell death signals in liver inflammation.
Brenner C; Galluzzi L; Kepp O; Kroemer G
J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism.
Trzaskalski NA; Fadzeyeva E; Mulvihill EE
Clin Med Insights Endocrinol Diabetes; 2020; 13():1179551420912972. PubMed ID: 32231442
[TBL] [Abstract][Full Text] [Related]
19. A fresh look at NASH pathogenesis. Part 1: the metabolic movers.
Larter CZ; Chitturi S; Heydet D; Farrell GC
J Gastroenterol Hepatol; 2010 Apr; 25(4):672-90. PubMed ID: 20492324
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
Asrih M; Jornayvaz FR
Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]